logo-loader

Cello Health PLC

Receive alerts
Market:
AIM
Market Cap:
£138.06 m
Price
129.50 GBX
Change
0.00%
52 weeks high
140.07
52 weeks low
95.00

In brief

We are a global healthcare-focused advisory group comprised of a set of leading clinical, commercial advisory and digital delivery capabilities.

We currently service 24 of the top 25 pharmaceutical clients globally as well as a wide range of biotech, diagnostics, devices and other key non-healthcare clients.

We enable clients to differentiate their propositions and drive brand success in ever more complex global markets. We deliver our services through nearly 1,000 highly skilled professionals utilising latest thinking, technology and digital solutions.

Cello Health plc delivers its services from an office network in the UK, USA, and Asia, with hub offices in New York, Philadelphia, London, Edinburgh, Farnham and Cheltenham.

Deep dive We explore the investor case for growth companies

Snapshot

  • Two divisions: Cello Health and Cello Signal
  • The group's dividend has risen every year for the past 13 years
  • Expansion in the US is key to future growth
  • Suitable acquisitions are being mulled to speed this aim